Director
Dr. Schneider has served as our director since January 2020. He was CEO of Omni Biopharmaceuticals Inc, a publicly traded biotech startup company, from 2013-2015. From 2010-2013, he provided R&D executive advisory and business development services to several large and small pharmaceutical companies, including an extensive role with Pfizer where he was engaged to facilitate strategic planning and decision-making for its early drug development pipeline.